Takeda Pharmaceutical
TAK
#332
Rank
โ‚น6.445 T
Marketcap
โ‚น2,017
Share price
1.68%
Change (1 day)
61.44%
Change (1 year)

Operating Margin for Takeda Pharmaceutical (TAK)

Operating Margin as of November 2026 (TTM): 1.74%

According to Takeda Pharmaceutical's latest financial reports and stock price the company's current Operating Margin is 1.74%. At the end of 2026 the company had an Operating Margin of -3.16%.

Operating Margin history for Takeda Pharmaceutical from 2009 to 2026

Operating Margin at the end of each year

Year Operating Margin Change
2026-3.16%-182.68%
20253.82%208.65%
20241.24%-86.71%
20239.31%9.86%
20228.48%-25.98%
202111.45%-720.42%
2020-1.85%-130.34%
20196.08%-50.4%
201812.27%48.23%
20178.28%24.09%
20166.67%-181.53%
2015-8.18%-187.12%
20149.39%9.87%
20138.55%-48.92%
201216.73%-36.08%
201126.18%-7.71%
201028.37%9.49%
200925.91%-38.25%
200841.96%-12.43%
200747.92%12.14%
200642.73%8.78%
200539.28%-4.35%
200441.07%-0.54%
200341.29%11.12%
200237.15%36.07%
200127.30%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Johnson & Johnson
JNJ
34.58% 1,887.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
22.03% 1,166.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
12.01% 590.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
28.40% 1,532.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
13.21% 659.20%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
32.40% 1,762.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
16.02% 820.69%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-30.69%-1,863.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
12.10% 595.40%๐Ÿ‡ฎ๐Ÿ‡ณ India

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.